SG10201800001VA - Compositions for oral administration of zoledronic acid or related compounds for treating disease - Google Patents

Compositions for oral administration of zoledronic acid or related compounds for treating disease

Info

Publication number
SG10201800001VA
SG10201800001VA SG10201800001VA SG10201800001VA SG10201800001VA SG 10201800001V A SG10201800001V A SG 10201800001VA SG 10201800001V A SG10201800001V A SG 10201800001VA SG 10201800001V A SG10201800001V A SG 10201800001VA SG 10201800001V A SG10201800001V A SG 10201800001VA
Authority
SG
Singapore
Prior art keywords
compositions
oral administration
related compounds
zoledronic acid
treating disease
Prior art date
Application number
SG10201800001VA
Inventor
Herriot Tabuteau
Original Assignee
Antecip Bioventures Ii Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/063,979 external-priority patent/US8802658B2/en
Application filed by Antecip Bioventures Ii Llc filed Critical Antecip Bioventures Ii Llc
Publication of SG10201800001VA publication Critical patent/SG10201800001VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
SG10201800001VA 2013-10-25 2014-08-08 Compositions for oral administration of zoledronic acid or related compounds for treating disease SG10201800001VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/063,979 US8802658B2 (en) 2012-05-14 2013-10-25 Compositions for oral administration of zoledronic acid or related compounds for treating disease
US14/279,241 US20140249317A1 (en) 2012-05-14 2014-05-15 Compositions for oral administration of zoledronic acid or related compounds for treating disease

Publications (1)

Publication Number Publication Date
SG10201800001VA true SG10201800001VA (en) 2018-02-27

Family

ID=52993341

Family Applications (3)

Application Number Title Priority Date Filing Date
SG11201603042TA SG11201603042TA (en) 2013-10-25 2014-08-08 Compositions for oral administration of zoledronic acid or related compounds for treating disease
SG10201609548UA SG10201609548UA (en) 2013-10-25 2014-08-08 Compositions for oral administration of zoledronic acid or related compounds for treating disease
SG10201800001VA SG10201800001VA (en) 2013-10-25 2014-08-08 Compositions for oral administration of zoledronic acid or related compounds for treating disease

Family Applications Before (2)

Application Number Title Priority Date Filing Date
SG11201603042TA SG11201603042TA (en) 2013-10-25 2014-08-08 Compositions for oral administration of zoledronic acid or related compounds for treating disease
SG10201609548UA SG10201609548UA (en) 2013-10-25 2014-08-08 Compositions for oral administration of zoledronic acid or related compounds for treating disease

Country Status (12)

Country Link
EP (1) EP3060220A4 (en)
JP (6) JP6166471B2 (en)
KR (3) KR20190009428A (en)
CN (2) CN105960240B (en)
AU (2) AU2014340649C1 (en)
CA (1) CA2928350C (en)
HK (1) HK1257400A1 (en)
IL (2) IL245287A0 (en)
MX (1) MX2016005396A (en)
MY (1) MY176246A (en)
SG (3) SG11201603042TA (en)
WO (1) WO2015060924A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10413560B2 (en) 2012-05-14 2019-09-17 Antecip Bioventures Ii Llc Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US9956238B2 (en) 2014-05-15 2018-05-01 Antecip Bioventures Ii Llc Compositions for administration of zoledronic acid or related compounds for treating low back pain
US10493085B2 (en) 2012-05-14 2019-12-03 Antecip Bioventures Ii Llc Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
US9999629B2 (en) 2012-05-14 2018-06-19 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US11654152B2 (en) 2012-05-14 2023-05-23 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating disease
US10350227B2 (en) 2012-05-14 2019-07-16 Antecip Bioventures Ii Llc Neridronic acid for treating complex regional pain syndrome
US10463682B2 (en) 2012-05-14 2019-11-05 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
US10413561B2 (en) 2012-05-14 2019-09-17 Antecip Bioventures Ii Llc Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
US10016445B2 (en) 2012-05-14 2018-07-10 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
EP3060220A4 (en) * 2013-10-25 2017-05-31 Antecip Bioventures II LLC Compositions for oral administration of zoledronic acid or related compounds for treating disease
WO2018079763A1 (en) 2016-10-28 2018-05-03 三菱ケミカル株式会社 Sizing agent for carbon fibers, aqueous dispersion of sizing agent for carbon fibers, and carbon fiber bundle to which sizing agent adheres

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
HUP0400096A2 (en) * 2001-05-02 2004-04-28 Novartis Ag. Pharmaceutical uses of bisphosphonates
US7875597B2 (en) * 2002-07-24 2011-01-25 New York University Treatment of spinal mechanical pain
WO2005005447A2 (en) * 2003-07-03 2005-01-20 Teva Pharmaceutical Industries Ltd. Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
AR046773A1 (en) * 2003-12-23 2005-12-21 Novartis Ag PHARMACEUTICAL FORMULATIONS OF BISPHOSPHONATES
PT2459176T (en) * 2009-07-31 2017-12-11 Gruenenthal Gmbh Crystallization method and bioavailability
PT2531200T (en) * 2010-02-06 2017-08-24 Gruenenthal Gmbh Crystallization method and bioavailability
US9340565B2 (en) * 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
ES2667535T3 (en) * 2012-05-14 2018-05-11 Antecip Bioventures Ii Llc Compositions comprising zoledronic acid or related compounds to relieve inflammatory pain and related conditions
EP3060220A4 (en) * 2013-10-25 2017-05-31 Antecip Bioventures II LLC Compositions for oral administration of zoledronic acid or related compounds for treating disease

Also Published As

Publication number Publication date
JP2017200941A (en) 2017-11-09
KR101739244B1 (en) 2017-05-23
SG10201609548UA (en) 2016-12-29
KR20170058444A (en) 2017-05-26
CN105960240A (en) 2016-09-21
EP3060220A4 (en) 2017-05-31
CN105960240B (en) 2018-04-20
MY176246A (en) 2020-07-24
KR20190009428A (en) 2019-01-28
CA2928350A1 (en) 2015-04-30
AU2017200832A1 (en) 2017-03-02
JP7136487B2 (en) 2022-09-13
IL245287A0 (en) 2016-06-30
JP6453387B2 (en) 2019-01-16
CA2928350C (en) 2018-01-09
SG11201603042TA (en) 2016-05-30
JP2024040304A (en) 2024-03-25
JP2016534081A (en) 2016-11-04
JP6802245B2 (en) 2020-12-16
JP2019059771A (en) 2019-04-18
WO2015060924A1 (en) 2015-04-30
JP2021028343A (en) 2021-02-25
AU2014340649C1 (en) 2017-05-18
MX2016005396A (en) 2017-03-01
IL254123A0 (en) 2017-10-31
AU2014340649B2 (en) 2016-11-17
KR20160062177A (en) 2016-06-01
JP6166471B2 (en) 2017-07-19
KR101975687B1 (en) 2019-05-07
EP3060220A1 (en) 2016-08-31
JP2022162105A (en) 2022-10-21
CN108434154A (en) 2018-08-24
HK1257400A1 (en) 2019-10-18

Similar Documents

Publication Publication Date Title
HK1257400A1 (en) Compositions for oral administration of zoledronic acid or related compounds for treating disease
EP2872151A4 (en) Acellular pro-tolerogenic compositions for the treatment/prevention of auto-immune diseases
IL241264A0 (en) Compounds and compositions for the treatment of parasitic diseases
PT2925757T (en) Compounds and compositions for the treatment of parasitic diseases
HK1217443A1 (en) Pharmaceutical compositions for oral treatment of diabetes
EP2968321A4 (en) Compounds for treatment of fibrosis diseases
HRP20190349T1 (en) Oral compositions for the treatment of gastroesophageal reflux disease
PT3524260T (en) Pharmaceutical compositions for treatment of inappetance
HK1215794A1 (en) Allogeneic autophagosome-enriched composition for the treatment of disease
HUE037179T2 (en) Pharmaceutical compositions for the treatment of muscular disorders
IL238592B (en) Compounds for treatment of liver diseases
ZA201508452B (en) Oral formulation for the treatment of cardiovascular diseases
IL234796B (en) Compounds for the treatment of ischemia-reperfusion-related diseases
HUE037176T2 (en) Oil-based pharmaceutical composition for the treatment of gastrointestinal diseases
EP2854539A4 (en) Phosphonate derivatives for treatment of alzheimer's disease
GB201407847D0 (en) Composition for the oral delivery of compounds
IL240119A0 (en) Pharmaceutical compositions for oral treatment of diabetes